Literature DB >> 17387701

Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia.

Scott C Borinstein, Min Xu, Douglas S Hawkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17387701     DOI: 10.1002/pbc.21193

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  11 in total

1.  Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia.

Authors:  T Bauters; V Mondelaers; H Robays; H De Wilde; Y Benoit; B De Moerloose
Journal:  Int J Clin Pharm       Date:  2010-11-06

2.  Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.

Authors:  S Kunzmann; W Thomas; B Mayer; S Kuhn; H Hebestreit
Journal:  Infection       Date:  2010-03-05       Impact factor: 3.553

3.  Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.

Authors:  Manzilat Akande; Anthony N Audino; Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Nov-Dec

4.  Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.

Authors:  Thomas Bontant; Sophie Le Garrec; David Avran; Stephane Dauger
Journal:  BMJ Case Rep       Date:  2014-08-12

5.  Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia.

Authors:  T Bauters; V Mondelaers; H Robays; H De Wilde; Y Benoit; B De Moerloose
Journal:  Int J Clin Pharm       Date:  2011-02-04

6.  Hemolytic anemia following rasburicase administration: a review of published reports.

Authors:  Annhien P Nguyen; Genevieve L Ness
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

7.  PharmGKB summary: methylene blue pathway.

Authors:  Ellen M McDonagh; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

Review 8.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Authors:  Ellen M McDonagh; Caroline F Thorn; John T Callaghan; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-09       Impact factor: 2.089

9.  Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin's Lymphoma.

Authors:  Mohammed A Alessa; Ann Kathryn Craig; James M Cunningham
Journal:  Am J Case Rep       Date:  2015-09-03

10.  Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.

Authors:  Garrett B Sherwood; Rita D Paschal; Jill Adamski
Journal:  Clin Case Rep       Date:  2016-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.